SCHEMBL4834531

SCHEMBL4834531

CN(C)c1cccc2cccc(S(=O)(=O)ON3C(=O)C4C(C3=O)C3C(=O)N(OS(=O)(=O)c5cccc6cccc(N(C)C)c56)C(=O)C43)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.44
▸ MAPT P10636 5/20 0.44
▸ GAA P10253 1/20 0.44
▸ ALDH1A1 P00352 6/20 0.38
▸ HPGD P15428 5/20 0.38
▸ KMT2A Q03164 3/20 0.37
▸ HTT P42858 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ ATM Q13315 1/20 0.36
▸ CA2 P00918 1/20 0.35
▸ LMNA P02545 3/20 0.35
▸ THRB P10828 1/20 0.35
▸ F2 P00734 4/20 0.34
▸ PRSS1 P07477 3/20 0.34
▸ PRSS2 P07478 3/20 0.34
▸ PRSS3 P35030 3/20 0.34
▸ HTR6 P50406 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4835319 0.89 KDM4E (0.41) KDM4EMAPTGAAALDH1A1HPGD
SCHEMBL4835914 0.79 KMT2A (0.30) KMT2AATM
SCHEMBL3827165 0.77 KDM4E (0.45) KDM4EMAPTGAAALDH1A1HPGD
SCHEMBL4834111 0.75 CA1 (0.46) KDM4EMAPTALDH1A1HPGDKMT2A
SCHEMBL3828119 0.73 KDM4E (0.41) KDM4EMAPTGAAALDH1A1HPGD
SCHEMBL8149846 0.72 CA2 (0.64) KDM4EMAPTGAAKMT2AHTT
SCHEMBL14845761 0.72 GAA (0.61) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL17322787 0.70 GAA (0.59) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL9676821 0.70 GAA (0.59) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL30116330 0.70 GAA (0.59) KDM4EMAPTGAAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 — — US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 — — US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 KDM4E 2501/4885MAPT 868/4885GAA 2435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback